FEB 01, 2021 7:31 AM PST

A Potential Leptospirosis Vaccine is Created

WRITTEN BY: Carmen Leitch

Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause disease in people. Leptospires are an infectious kind of spirochete that cause leptospirosis, a zoonotic disease that can spread when people or animals come into contact with contaminated water, soil, or the urine of infected animals. Infected animals can harbor the bacteria in their kidneys.

An SEM image revealing some of the ultrastructural features of two, spiral-shaped, Leptospira interrogans bacteria bound to a 0.2 µm filter. / Credit: CDC/ Rob Weyant

Leptospirosis can cause life-threatening conditions. A vaccine is necessary because leptospirosis is a public health problem, and the bacteria are too common to be eradicated. But the Leptospira family of bacteria includes 300 different varieties or serovars that make up 64 species. That makes creating an effective vaccine difficult.

However, researchers have now developed a single-dose vaccine that may provide protection from the many types of bacteria that cause leptospirosis. They did so by utilizing a protein that is important to the movement of the pathogen. The work has been reported in eLife.

"We have recently identified a novel protein called FcpA in the flagella of Leptospira which enables it to move and penetrate human and animal tissues," explained the first study author Elsio Wunder Jr, an Associate Research Scientist in Epidemiology at Yale School of Public Health. "With this study, we wanted to see whether using engineered Leptospira that lacks a functional FcpA molecule has the potential for a vaccine that could provide [a] major public health benefit."

The modified form of Leptospira that the researchers created is a live vaccine: one that uses a non-pathogenic type of the infectious microbe. The scientists tested the safety of the vaccine in hamster and mouse models, and found that it moved through the hamster and was cleared within seven days of exposure, while the mice cleared it from their bodies after two weeks had elapsed. The mutated form of Leptospira was not found in samples of kidney tissue or blood after those time points, which suggested that the vaccine would be cleared from the body before causing disease.

The researchers then checked for efficacy against all Leptospira infections by testing the vaccine against a heat-killed form of Leptospira. When animal models were given either the modified form or the heat-killed form of Leptospira, the researchers found that the heat-killed vaccine could only protect the animals from serovars of Leptospira that were similar to it. The altered form, however, was effective against serovars that belonged to different species of the bacteria; the engineered vaccine seems to be effective.

Further research indicated that the vaccinated hamsters and mice were generating antibodies against a range of Leptospira proteins from different species. The scientists also identified 41 proteins that could be useful in the development of other vaccines; many of them are similar in different species and could be essential to the survival of the pathogen.

"In this proof-of-concept study, we have shown that a universal leptospirosis vaccine candidate can prevent both death and kidney colonization in animal models," said author Albert Ko, Department Chair and Professor of Epidemiology (Microbial Diseases) at Yale School of Public Health. "These findings take us one step closer to achieving the holy grail for the field, which is an effective vaccine that protects against the many Leptospira species and can be deployed as a broad solution to the human and animal health challenge caused by leptospirosis."

Sources: AAAS/Eurekalert! via eLife Sciences, eLife

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 25, 2021
Immunology
The Immune System Impairs Antibiotic Effectiveness
MAR 25, 2021
The Immune System Impairs Antibiotic Effectiveness
Nitric oxide, a molecule produced by the immune system, can negatively impact antibiotics’ effectiveness, says a s ...
MAR 23, 2021
Immunology
Assay Detects Antibodies in Asymptomatic COVID Carriers
MAR 23, 2021
Assay Detects Antibodies in Asymptomatic COVID Carriers
It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of th ...
APR 25, 2021
Cell & Molecular Biology
Natural Molecules Can Stop Antibodies From Neutralizing SARS-CoV-2
APR 25, 2021
Natural Molecules Can Stop Antibodies From Neutralizing SARS-CoV-2
When we're exposed to a pathogen, our immune system normally mounts a robust response against it. Antibodies are generat ...
APR 29, 2021
Immunology
A Week for World Immunization
APR 29, 2021
A Week for World Immunization
The World Health Organization (WHO) is calling our attention to World Immunization Week, which comes in the last week of ...
MAY 03, 2021
Microbiology
A New Bacterial Defense System is Discovered
MAY 03, 2021
A New Bacterial Defense System is Discovered
Most DNA that we're familiar with is found in cells in a double-stranded form. So, many years ago, scientists were intri ...
JUN 01, 2021
Microbiology
A Closer Look at a Potential Bioweapon
JUN 01, 2021
A Closer Look at a Potential Bioweapon
Francisella tularensis is a naturally occurring bacterium found throughout the Northern Hemisphere that is extremely vir ...
Loading Comments...